Skip to main content

Table 3 Cluster-adjusted mean scores and differences by subgroups

From: No difference in effects of ‘PACE steps to success’ palliative care program for nursing home residents with and without dementia: a pre-planned subgroup analysis of the seven-country PACE trial

Individual subgroups

Baseline scores (T0)

Post-intervention scores (T1 + T2) d

Baseline-adjusted mean difference intervention versus control group post-intervention

Control

Intervention

Control

Intervention

Cases No.

Meanb

Cases No.

Meanb

Cases No.

Meanb

Cases No.

Meanb

Comfort in the last week of lifea

 Advanced dementia

n = 99

n = 78

n = 136

n = 104

0.2

91

30.6

74

30.8

131

30.3

97

30.7

 Non-advanced dementia

n = 65

n = 61

n = 167

n = 110

0.8

60

30.0

57

30.0

157

31.0

102

31.8

 Without dementia

n = 74

n = 82

n = 157

n = 137

−1.9

70

29.7

75

30.6

146

31.3

128

30.2

Quality of care and dying in the last month of lifeb

 Advanced dementia

n = 99

n = 78

n = 136

n = 104

3.6

97

38.1

75

37.1

135

38.0

103

40.6

 Non-advanced dementia

n = 65

n = 61

n = 167

n = 110

2.7

65

38.4

59

38.3

163

39.5

104

42.2

 Without dementia

n = 74

n = 82

n = 157

n = 137

4.2

74

41.2

78

39.3

152

39.8

133

42.2

  1. All mean differences between groups post-intervention are cluster and baseline adjusted
  2. Abbreviations: CAD-EOLD Comfort Assessment in Dying – End of Life in Dementia, QOD-LTC Quality of Dying in Long Term Care
  3. a Comfort in the last week of life was measured using CAD-EOLD scale (total scores range 14–42). Higher scores indicate better quality of dying
  4. b Quality of care and dying in the last month of life was measured using QOD-LTC scale (total scores range 11–55). Higher scores indicate better quality of end-of-life care
  5. c Total scores are averages per subscale multiplied by total number of items. Cases with missing data on more than 50% of items per subscale were excluded from the calculation of the total scale scores
  6. d Post intervention measurements collected for residents at T1 (=month 13) and T2 (=month 17)